Condition
Vivax Malaria clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Vivax Malaria clinical trials that are recruiting, at sites in 4 countries (most in Brazil (2), Ethiopia (2), Papua New Guinea (2)). By phase: Phase 3 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 4Countries
All recruiting trials (2)
-
High-dose daily and weekly primaquine for vivax malaria in people with reduced G6PD activity
This will test whether 1 mg/kg daily primaquine for 7 days is safe and works for adults with P. vivax and intermediate G6PD, and whether 0.75 mg/kg weekly primaquine is safe and works for adults with G6PD deficiency.
-
Revised tafenoquine dosing for treating vivax malaria
This study is testing a new weight-based dose of tafenoquine to see if it works as well or better than current treatments for people with vivax malaria.
Quick answers
How many Vivax Malaria clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Brazil (2 trials), Ethiopia (2 trials), Papua New Guinea (2 trials), Indonesia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.